1. Home
  2. HRB vs PRAX Comparison

HRB vs PRAX Comparison

Compare HRB & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$42.18

Market Cap

5.7B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$312.49

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
PRAX
Founded
1955
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
8.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HRB
PRAX
Price
$42.18
$312.49
Analyst Decision
Sell
Strong Buy
Analyst Count
2
13
Target Price
$55.00
$397.85
AVG Volume (30 Days)
1.4M
616.0K
Earning Date
02-03-2026
02-27-2026
Dividend Yield
4.00%
N/A
EPS Growth
9.63
N/A
EPS
4.50
N/A
Revenue
$3,770,736,000.00
$7,463,000.00
Revenue This Year
$4.28
N/A
Revenue Next Year
$3.14
$14,827.76
P/E Ratio
$9.29
N/A
Revenue Growth
4.15
364.98
52 Week Low
$41.17
$26.70
52 Week High
$64.62
$326.91

Technical Indicators

Market Signals
Indicator
HRB
PRAX
Relative Strength Index (RSI) 39.95 66.64
Support Level $41.94 $266.93
Resistance Level $45.24 $306.16
Average True Range (ATR) 1.07 17.82
MACD -0.08 -1.32
Stochastic Oscillator 10.20 78.28

Price Performance

Historical Comparison
HRB
PRAX

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: